Jessica M Pouso-Diz1, Jose M Abalo-Lojo2, Francisco Gonzalez3,2. 1. Department of Surgery and Medicosurgical Specialties and CIMUS, University of Santiago de Compostela, Santiago de Compostela, Spain. jessy7_pd@hotmail.com. 2. Service of Ophthalmology and IDIS, Complejo Hospitalario Universitario de Santiago de Compostela, Santiago de Compostela, Spain. 3. Department of Surgery and Medicosurgical Specialties and CIMUS, University of Santiago de Compostela, Santiago de Compostela, Spain.
Abstract
INTRODUCTION: Thyroid eye disease (TED) is the most frequent extra-thyroid manifestation of Graves' disease and it is more frequent in middle age and in female gender. Nowadays, the causal mechanisms of this disease are not completely understood, but the current available studies suggest that the main causative factor is the thyroid stimulating hormone receptor. MATERIALS AND METHODS: To collect reports on TED medical management, a thorough literature search was performed in PubMed database. An additional search was made in Google Scholar to complete the collected items. RESULTS: Among the indentified risk factors, tobacco habit is the most relevant. The main criteria to choose a suitable treatment are the activity and severity of the disease. Support measures can be used to improve the patient's symptoms in any phase of the disease. There is a large number of drugs proposed to manage TED, although with different reported rates of success. CONCLUSIONS: Currently, the drugs of choice are corticosteroids in moderate-to-severe and in sight-threatening forms. The main problem of corticosteroids is their spectrum of side effects. Therefore, other alternatives are being suggested for medical management of this disease. The efficacy of these alternatives remains unclear.
INTRODUCTION:Thyroid eye disease (TED) is the most frequent extra-thyroid manifestation of Graves' disease and it is more frequent in middle age and in female gender. Nowadays, the causal mechanisms of this disease are not completely understood, but the current available studies suggest that the main causative factor is the thyroid stimulating hormone receptor. MATERIALS AND METHODS: To collect reports on TED medical management, a thorough literature search was performed in PubMed database. An additional search was made in Google Scholar to complete the collected items. RESULTS: Among the indentified risk factors, tobacco habit is the most relevant. The main criteria to choose a suitable treatment are the activity and severity of the disease. Support measures can be used to improve the patient's symptoms in any phase of the disease. There is a large number of drugs proposed to manage TED, although with different reported rates of success. CONCLUSIONS: Currently, the drugs of choice are corticosteroids in moderate-to-severe and in sight-threatening forms. The main problem of corticosteroids is their spectrum of side effects. Therefore, other alternatives are being suggested for medical management of this disease. The efficacy of these alternatives remains unclear.
Authors: G Vannucchi; I Campi; D Covelli; D Dazzi; N Currò; S Simonetta; R Ratiglia; P Beck-Peccoz; M Salvi Journal: J Clin Endocrinol Metab Date: 2009-06-30 Impact factor: 5.958
Authors: Allison N McCoy; Denise S Kim; Erin F Gillespie; Stephen J Atkins; Terry J Smith; Raymond S Douglas Journal: J Clin Endocrinol Metab Date: 2014-03-26 Impact factor: 5.958
Authors: K E Morgenstern; J Evanchan; J A Foster; K V Cahill; J A Burns; D E E Holck; J D Perry; A E Wulc Journal: Ophthalmic Plast Reconstr Surg Date: 2004-05 Impact factor: 1.746
Authors: Mohammad Taher Rajabi; Seyed Mohsen Rafizadeh; Abbas Mohammadi; Bahram Eshraghi; Nader Mohammadi; Seyedeh Simindokht Hosseini; Mohammad Bagher Rajabi; Mohammad Mohsen Keshmirshekan; Mansoor Shahriari; Seyedeh Zahra Poursayed Lazarjani; Mohammad Mehdi Parandin Journal: Front Med (Lausanne) Date: 2022-02-11